A new AI algorithm developed by researchers from the University of Western Australia has been found to better predict the ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Phil, a company focused on pharmaceutical commercialization, has secured $60 million in growth debt financing from K2 HealthVentures. The company's PhilRx platform provides prescription services to ...

Editor's note: This story has been updated with additional information on Pear's financial state. The assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold ...

Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization ...

Flinders University has developed an online program that seeks to improve the way people with inflammatory bowel disease (IBD ...

A new study has looked into factors influencing doctors, chronically ill patients, and healthy persons to prefer one health ...

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

In a corporate disclosure, the company noted that it will remain listed on the Australian Securities Exchange as MedAdvisor ...

The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a ...

Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.